ADHD is a developmental disorder associated with cognitive, emotional, and behavioral deficits. Its main symptoms are impulsivity, hyperactivity, and inattention (American Psychiatric Association, 2000). It is one of the most common psychiatric pathologies in children with an estimated prevalence of 8-12% worldwide, and symptoms persist until adulthood in up to two-third of cases. Numerous studies have demonstrated the interactions between ADHD and other disorders that may aggravate the symptoms or the long-term outcome of the disease. Indeed, associations have been described with impaired perceptual function, and particularly pain.
(1) The current knowledge on the disease, treatments and sensory comorbidity (i.e. alteration of pain perception) will be presented through Master classes. The clinical impact of the disease will be explained. The use of animal models to unravel underlying neurobiological mechanisms in a translational perspective will be assessed and neuroinflammatory processes will
Then, the attendees will be invited to think about the interactions between comorbid disorders and their societal outcomes. More particularly:
(2) They will be asked to participate in mini-challenges with the objective to (i) raise hypothesis on comorbidity mechanisms, treatment-induced side effects, and (ii) elaborate scientific strategies to test their hypothesis.
(3) They will participate to concomitant round tables to discuss (i) the societal representation and acceptance of, or myths associated to, the disease, (ii) the consequences of comorbidity on well-being and therapeutical strategies, (iii) the possible increased prevalence of ADHD, and (iv) the translation of basic research into clinical applications through a bench to bedside approach.
The spokespersons of the mini-teams and of the round tables will present their conclusions and the course organizers will make a synthesis of attendee’s reflections.
Aims of the course
Understanding the ADHD disease: symptoms, nerurobiological mechanisms, treatment opportunities.
Capturing and understanding interactions with comorbid disorders and their clinical consequences.
Reflecting on the burden associated to ADHD and its worsening due to comorbidities.
Raising scientific hypothesis
Elaborating scientific strategies to develop hypothesis-driven pre-clinical experiments or clinical studies
Proposing new actions for a public outreach strategy, thus limiting the propagation of distorted understanding by the lay public.
Improving team work capacity
Developping the competence to synthesize different visions and elaborate a final, common proposal
Developping a person centered holistic view in a clinical context
Institution or company
University of Bordeaux
Institute of Neurodegenerative Diseases
Centre Broca-Nouvelle Aquitaine
Activity directed to
Expected number of public
Number of days
Dates in which the activity could NOT be held
From 24 June 2021 to 11 July 2021
Preferred dates to celebrate the activity
From July 13 to end of July 2021
Gipuzkoa - Donostia/San Sebastian
Financiado por la Fundación en su totalidad
Sustainable Development Goals
Good health and well-being
Face-to-face + Live online (via ZOOM)
Face-to-face + live online: Master class
08:45 - 09:00 Registration
09:00 - 09:15
Presentation by the Director of the activity
Speaker: Marc Landry
Institution: University of Bordeaux
Language of the lecture: English
09:15 - 10:00
General characteristics of ADHD: clinical symptoms, epidemiology, comorbidity.
Speaker: Nora Kerekes
Institution: University West
Language of the lecture: English
08:45 - 09:00